• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 8th February 2017

How Should We Choose the Measure of ‘Average’ Preferences?

New OHE Research Paper: What is the normative basis for selecting the measure of ‘average’ preferences for use in social choices? Value sets for preference-based patient-reported outcome measures aim to provide, for each health state defined by the measure, a…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

New OHE Research Paper: What is the normative basis for selecting the measure of ‘average’ preferences for use in social choices?

Value sets for preference-based patient-reported outcome measures aim to provide, for each health state defined by the measure, a single utility value that reflects the average preferences of the general public. But what precisely do ‘average preferences’ mean in this context? There are a number of ways of combining numbers representing the utilities of individuals to achieve an average reflection of society’s preferences.

EQ-5D valuation research typically relies on means, although the median has also been used. These reflect quite different things: the average of peoples’ values, as opposed to the value of the average person. Still other approaches are possible, including the geometric mean, mode, or indeed any of the above taken together with various rules about the exclusion of outliers (in effect, a judgement about whose votes should count).

Which approach to aggregation of individual preferences is chosen can have an important effect on conclusions about what ‘society’s’ preferences are – with implications for decision making and the allocation of public funds. Which approach to calculating the average should be used is a normative question: it cannot be answered with recourse to empirical evidence alone. The choice of summary statistics is not merely a technical matter, but invokes ethical issues that need to be resolved.

These issues are explored in a new OHE Research Paper entitled: What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices? The paper is authored by Professor Nancy Devlin and Koonal Shah of OHE, in collaboration with Ken Buckingham. The aim of the paper is to consider what normative arguments might exist for advocating the use of any given measure of the average in the context of health state values.

The paper begins by providing examples of the importance and implications of the choice of measure of central tendency in stated preference studies. Then, drawing on the theory of social choice, voting models and welfare economics, the authors consider the criteria that are available for judging the ‘goodness’ of alternative approaches to aggregation, and evaluate their relevance to the selection of the measure of average EQ-5D values.

This paper builds on research that was funded by a Department of Health Policy Research Programme grant (NIHR PRP 070/0073).

Access the OHE Research Paper here.

For more information about OHE’s research on this topic, contact Nancy Devlin.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Research Papers

Related News

  • News
  • December 2020

Should We ‘Drop Dead’ from Health State Valuation?

Read more
  • News
  • September 2020

Cornerstones of ‘Fair’ Drug Coverage

Read more
  • News
  • January 2020

Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead

Read more
  • News
  • September 2019

HTA and Payment Mechanisms for New Drugs to Tackle AMR

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!